Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Journal of Physical Education and Sport ; 23(1):143-151, 2023.
Article in English | Scopus | ID: covidwho-2238552


Problem statement. The COVID-19 pandemic effect led to a reduction in psychological, social, and physical wellbeing, due to social isolation and sedentariness. Interventions are needed to prevent and improve wellbeing, especially among adult women, for whom the greatest health problems arisen. Ecological exercise can produce greater health benefits than indoor training, including improved humor, self-esteem, physical fitness and reduced stress, anxiety, and depression. Nordic Walking (NW) is an ecological activity, whose beneficial effects can be extended to both healthy people and those with diseases. However, we had to try to understand the motivations that make an individual, especially in adulthood, choose to engage in physical activity (PA), using the push-pull motivational framework. Purpose. The aim of the study was to investigate the adult women's motivations to practice PA post-COVID-19, the relationship among the variables analyzed, and their perceptions about the intention to practice NW in the future, to improve their physical, social, and mental wellbeing. Methods. A convenience sample of 65 women (50.07 ± 7.85 years old) was recruited for the study. A structured questionnaire was formulated, based on a thorough literature review, consisting of three sections: demographic characteristics, pull-push motivational factors to PA and future intention to perform NW. Results. Most adult women did not perform PA because of the boredom caused by the repetition of exercises and for fear of infection. However, they would prefer to practice outdoor activities in the future, including NW, through a teaching method different from the prescriptive one, the solution to which could be the heuristic learning. Motivations to take part in PA course varied according to the age: the younger ones had the need to improve their mental and physical state, while the older ones the need for social and autonomy. Conclusions. Future studies should focus on implementing an original and innovative protocol, that is not performance-oriented, but also aimed to improve social and mental wellbeing. The utility of the study is to provide more information to wellness instructors to attract potential customers to participate in PA courses. © JPES.

Pulmonology ; 28(6): 419-420, 2022.
Article in English | MEDLINE | ID: covidwho-2126565

Vaccination , Humans
Clin Microbiol Infect ; 26(7): 880-894, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-172186


BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become epidemic in Italy and other European countries. The disease spectrum ranges from asymptomatic/mildly symptomatic presentations to acute respiratory failure. At the present time the absolute number of severe cases requiring ventilator support is reaching or even surpassing the intensive care unit bed capacity in the most affected regions and countries. OBJECTIVES: To narratively summarize the available literature on the management of COVID-19 in order to combine current evidence and frontline opinions and to provide balanced answers to pressing clinical questions. SOURCES: Inductive PubMed search for publications relevant to the topic. CONTENT: The available literature and the authors' frontline-based opinion are summarized in brief narrative answers to selected clinical questions, with a conclusive statement provided for each answer. IMPLICATIONS: Many off-label antiviral and anti-inflammatory drugs are currently being administered to patients with COVID-19. Physicians must be aware that, as they are not supported by high-level evidence, these treatments may often be ethically justifiable only in those worsening patients unlikely to improve only with supportive care, and who cannot be enrolled onto randomized clinical trials. Access to well-designed randomized controlled trials should be expanded as much as possible because it is the most secure way to change for the better our approach to COVID-19 patients.

Anti-Inflammatory Agents/therapeutic use , Antiviral Agents/therapeutic use , Betacoronavirus/drug effects , Coronavirus Infections/drug therapy , Off-Label Use/ethics , Pneumonia, Viral/drug therapy , COVID-19 , Coronavirus Infections/epidemiology , Humans , Intensive Care Units/statistics & numerical data , Italy/epidemiology , Lung Diseases/drug therapy , Lung Diseases/pathology , Lung Diseases/virology , Pandemics , Pneumonia, Viral/epidemiology , Respiration, Artificial/methods , SARS-CoV-2